Literature DB >> 11418638

Oral exposure to alloantigen generates intragraft CD8+ regulatory cells.

J Zhou1, R I Carr, R S Liwski, A W Stadnyk, T D Lee.   

Abstract

We have previously reported that oral administration of allogeneic rat spleen cells before kidney allotransplantation significantly prolongs graft survival. This prolongation was alloantigen specific and was associated with a decrease in graft-infiltrating cells (GIC) and an increase in transcription of IL-4 mRNA in the GIC. In this study increased splenic mixed lymphocyte responses from animals orally exposed to alloantigen before kidney transplantation suggested that the kidney allograft prolongation was not due to a masking of allorecognition, but to an immunomodulation of the immune response. We have assessed GIC T cell subsets on day 5 post-transplant and found decreased numbers of CD4(+) T cells in fed animals compared with controls, but there was no change in CD8(+) T cell numbers. The CD8(+) GIC from fed animals transcribed substantial levels of perforin, granzyme, and Fas ligand mRNA, indicating the presence of active CTL. Direct CTL assays showed that the GIC from fed recipients exhibited higher allo-CTL activity than GIC from control unfed recipients. In addition, the CD8(+) GIC exhibited high levels of IL-4 mRNA, suggesting Tc2-type regulatory cells. Prolonged graft survival in the face of active CTL and Tc2 cells suggests the presence of a CD8(+) regulatory cell population in the allograft. To confirm this, cell transfer experiments were performed. Prolongation of graft survival was transferred from rats orally exposed to alloantigen to naive animals by transfer of CD8(+) GIC. This is the first report that oral exposure to alloantigen prolongs kidney allograft survival by the generation of intragraft CD8(+) regulatory cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418638     DOI: 10.4049/jimmunol.167.1.107

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.

Authors:  Zhenhua Dai; Qi Li; Yinong Wang; Ge Gao; Lonnette S Diggs; George Tellides; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 2.  Identification and characterization of CD8+ suppressor T cells.

Authors:  James C Zimring; Judith A Kapp
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

5.  Phenotype and function of regulatory T cells in the genital tract.

Authors:  Janina Jiang; Kathleen A Kelly
Journal:  Curr Trends Immunol       Date:  2011

Review 6.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Working toward immune tolerance in lung transplantation.

Authors:  Xinguo Jiang; Mark R Nicolls
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

8.  CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.

Authors:  Carole Guillonneau; Marcelo Hill; François-Xavier Hubert; Elise Chiffoleau; Caroline Hervé; Xian-Liang Li; Michèle Heslan; Claire Usal; Laurent Tesson; Séverine Ménoret; Abdelhadi Saoudi; Brigitte Le Mauff; Régis Josien; Maria Cristina Cuturi; Ignacio Anegon
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 9.  Oral tolerance.

Authors:  Henry Yim Wu; Howard L Weiner
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

10.  Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressants.

Authors:  Christopher Glenn Wallace; Chia-Hung Yen; Hsiang-Chen Yang; Chun-Yen Lin; Ren-Chin Wu; Wei-Chao Huang; Jeng-Yee Lin; Fu-Chan Wei
Journal:  Clin Dev Immunol       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.